- Home
- SGHT vs PVBC Comparison
SGHT vs PVBC Comparison
Compare SGHT & PVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- PVBC
- Stock Information
- Founded
- SGHT 2011
- PVBC 1913
- Country
- SGHT United States
- PVBC United States
- Employees
- SGHT N/A
- PVBC N/A
- Industry
- SGHT Medical Specialities
- PVBC Major Banks
- Sector
- SGHT Health Care
- PVBC Finance
- Exchange
- SGHT Nasdaq
- PVBC Nasdaq
- Market Cap
- SGHT 193.2M
- PVBC 224.8M
- IPO Year
- SGHT 2021
- PVBC 2015
- Fundamental
- Price
- SGHT $5.82
- PVBC $12.87
- Analyst Decision
- SGHT Buy
- PVBC Hold
- Analyst Count
- SGHT 8
- PVBC 1
- Target Price
- SGHT $4.64
- PVBC $12.50
- AVG Volume (30 Days)
- SGHT 215.5K
- PVBC 68.0K
- Earning Date
- SGHT 11-06-2025
- PVBC 10-23-2025
- Dividend Yield
- SGHT N/A
- PVBC N/A
- EPS Growth
- SGHT N/A
- PVBC 131.87
- EPS
- SGHT N/A
- PVBC 0.74
- Revenue
- SGHT $76,052,000.00
- PVBC $62,100,000.00
- Revenue This Year
- SGHT N/A
- PVBC $9.73
- Revenue Next Year
- SGHT $12.04
- PVBC $4.87
- P/E Ratio
- SGHT N/A
- PVBC $17.44
- Revenue Growth
- SGHT N/A
- PVBC 12.27
- 52 Week Low
- SGHT $2.03
- PVBC $10.38
- 52 Week High
- SGHT $5.86
- PVBC $13.02
- Technical
- Relative Strength Index (RSI)
- SGHT 77.35
- PVBC 54.70
- Support Level
- SGHT $4.86
- PVBC $12.48
- Resistance Level
- SGHT $5.12
- PVBC $12.86
- Average True Range (ATR)
- SGHT 0.27
- PVBC 0.17
- MACD
- SGHT 0.03
- PVBC 0.01
- Stochastic Oscillator
- SGHT 95.56
- PVBC 56.52
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About PVBC Provident Bancorp Inc. (MD)
Provident Bancorp Inc provides a range of banking products and services to small and medium-sized commercial customers. It attracts deposits from the general public and uses those funds to originate loans, commercial real estate, construction and land, and commercial business loans, and to invest in securities. The company lending activities include providing commercial real estate loans, multi-family residential real estate loans, commercial business loans, construction and land development loans, one-to four-family residential loans, home equity loans & lines of credit, and consumer loans.